Xiangxue Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
April 22, 2022 at 06:26 pm IST
Share
Xiangxue Pharmaceutical Co.,Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 2,929.71 million compared to CNY 2,923.48 million a year ago. Revenue was CNY 2,970.58 million compared to CNY 3,072.09 million a year ago. Net loss was CNY 688.47 million compared to net income of CNY 98.42 million a year ago. Basic loss per share from continuing operations was CNY 1.04 compared to basic earnings per share from continuing operations of CNY 0.15 a year ago. Diluted loss per share from continuing operations was CNY 1.04 compared to diluted earnings per share from continuing operations of CNY 0.15 a year ago.
XIANGXUE PHARMACEUTICAL CO.,LTD. is a China-based company principally engaged in the research, development, production and distribution of traditional Chinese medicines and herbal decoction pieces. The Company's main products include antiviral oral liquids, indigowoad root granules, Exocarpium Citri Reticulatae series Chinese patent drugs and herbal decoction pieces, among others. The Company is also involved in the manufacture and sale of medical devices, health products, soft drinks and biological products. The Company distributes its products in domestic market.